J Surg Oncol
-
Publication Venue For
- Regional control after precision lymph node dissection for clinically evident melanoma metastasis.. 127:140-147. 2023
- Racial-ethnic variations in phyllodes tumors among a multicenter United States cohort. 2022
- Investigating readmission rates for patients undergoing oncologic resection and endoprosthetic reconstruction for primary sarcomas and tumors involving bone.. 126:356-364. 2022
- How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent.. 125:712-718. 2022
- Opioid prescribing exceeds consumption following common surgical oncology procedures.. 123:352-356. 2021
- The effect of sarcopenia on perioperative complications in abdominally based free-flap breast reconstruction.. 122:1240-1246. 2020
- Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high-grade soft tissue sarcomas of the extremities.. 122:884-896. 2020
- Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow.. 120:160-167. 2019
- The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.. 120:132-141. 2019
- Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.. 119:694-699. 2019
- Updates in adjuvant systemic therapy for melanoma.. 119:222-231. 2019
- A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.. 118:469-476. 2018
- Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?. 117:1584-1588. 2018
- Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?. 117:1708-1715. 2018
- Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.. 117:634-643. 2018
- Transected thin melanoma: Implications for sentinel lymph node staging.. 117:567-571. 2018
- Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.. 117:284-289. 2018
- Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.. 116:969-982. 2017
- Perioperative fluid and hemodynamic management within an enhanced recovery pathway.. 116:592-600. 2017
- Recurrence patterns following irreversible electroporation for hepatic malignancies.. 115:704-710. 2017
- Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?. 115:376-383. 2017
- Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing liver resection for neoplastic disease.. 115:402-406. 2017
- Evolving application of minimally invasive cancer operations at a tertiary cancer center.. 115:365-370. 2017
- Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.. 113:477-484. 2016
- Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.. 113:188-193. 2016
- Neoadjuvant use of ipilimumab in locally advanced melanoma.. 112:841-843. 2015
- Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.. 112:352-358. 2015
- Morphomics predicts response to ipilimumab in patients with stage IV melanoma.. 112:333-337. 2015
- Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.. 112:46-50. 2015
- Impact of delayed lymphoscintigraphy for sentinel lymphnode biopsy for breast cancer.. 111:931-934. 2015
- Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma.. 110:682-688. 2014
- Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma.. 110:412-415. 2014
- Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy.. 110:400-406. 2014
- Breast conservation: is the survival better for mastectomy?. 110:58-61. 2014
- Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.. 109:533-541. 2014
- Assessment of multimodality therapy use for extremity sarcoma in the United States.. 109:395-404. 2014
- Partnering with engaged patients accelerates research.. 109:504-505. 2014
- Isolated limb infusion as a model to test new agents to treat metastatic melanoma.. 109:357-365. 2014
- Pancreatic metastasectomy: the Memorial Sloan-Kettering experience and a review of the literature.. 109:28-30. 2014
- Intraoperative fluid management and complications following pancreatectomy.. 107:529-535. 2013
- Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.. 107:307-311. 2013
- Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease.. 106:953-958. 2012
- Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.. 106:357-362. 2012
- Effect of surgeon specialization on long-term survival following colon cancer resection at an NCI-designated cancer center.. 106:219-223. 2012
- Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?. 106:111-118. 2012
- Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma.. 105:81-84. 2012
- Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.. 100:144-148. 2009
- Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.. 100:8-12. 2009
- A rationale for the targeted treatment of oligometastases with radiotherapy.. 98:202-206. 2008
- Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast. 2022
- Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma. 2020
- Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients. 2017